CN Patent
CN105708805A — 一种还原型羧烷基葡聚糖铁及其制备方法
Assigned to Shanxi Powerdone Pharmaceutical Co Ltd · Expires 2016-06-29 · 10y expired
What this patent protects
本申请公开了一种还原型羧烷基葡聚糖铁及其制备方法,该还原型羧烷基葡聚糖铁为纳米颗粒,具有安全性高、诱发过敏等反应几率低的特点,能够有效降低高浓度的铁离子对人体的副反应,可以大幅减少静脉注射的时间,生物活性高、效果好、副反应少、同时大大减少给药次数。
USPTO Abstract
本申请公开了一种还原型羧烷基葡聚糖铁及其制备方法,该还原型羧烷基葡聚糖铁为纳米颗粒,具有安全性高、诱发过敏等反应几率低的特点,能够有效降低高浓度的铁离子对人体的副反应,可以大幅减少静脉注射的时间,生物活性高、效果好、副反应少、同时大大减少给药次数。
Drugs covered by this patent
- Injectafer (FERRIC CARBOXYMALTOSE) · Am Regent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.